Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Mydriatic Eyedrops Market by Type (Atropine, Homatropine, Dolly, Others), By Application (Adult, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Mydriatic Eyedrops Market by Type (Atropine, Homatropine, Dolly, Others), By Application (Adult, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130252 3300 Pharma & Healthcare 377 240 Pages 4.5 (50)

Market Overview:

The global mydriatic eyedrops market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye disorders, rising awareness about eye care, and technological advancements in the field of ophthalmology. Based on type, the global mydriatic eyedrops market is segmented into atropine, homatropine, dolly, and others. The atropine segment is expected to account for the largest share of the global mydriatic eyedrops market in 2018. This segment is also projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to its high efficacy and safety profile. Based on application, the global mydriatic eyedrops market is divided into adult and children segments. The adult segment accounted for majority share of this market in 2017 and is projected to grow at a CAGR of 5% duringthe forecast period from 2018to 2030 owingto an increasein demandfor better treatment optionsfor variouseye disordersamong adults worldwide .

Global Mydriatic Eyedrops Industry Outlook

Product Definition:

Mydriatic eyedrops are used to dilate the pupil of the eye. This is done in order to allow for a better view of the inside of the eye, and to help diagnose certain eye conditions. Mydriatic eyedrops can also be used to treat glaucoma.


Atropine is a tropane alkaloid that is found in the medicinal plant belladonna. Atropine acts as an anticholinergic drug and blocks the release of acetylcholine, a chemical messenger that facilitates nerve excitation. It also inhibits the parasympathetic nervous system which controls bladder function and respiration.


Homatropine is a tropane alkaloid and is found in the medicinal plant Asclepias syriaca. It has potent anticholinergic, anti-inflammatory and local anesthetic properties. The drug has been used in traditional medicines to treat cold symptoms, gastrointestinal conditions as well as eye drops for mydriatic (making them itchy) effect.

The global eyedrops market was valued at USD 469 million in 2016.

Application Insights:

The adult segment held the largest share of over 70.0% in 2017. The application of mydriatic eyedrops is most commonly found in patients suffering from glaucoma, ocular allergies, and other eye diseases such as iritis or uveitis. In addition, a growing number of patients with moderate to severe dry eyes is expected to contribute towards market growth during the forecast period.

Glaucoma is one of the leading causes for blindness worldwide and was estimated to affect nearly 7 million people across the globe in 2016 according to data published by IASO International Association for Prevention & Detection of Eye Diseases (IAPB). Growing awareness about this disease coupled with increasing availability of advanced diagnostic tools has led to an increase in its incidence over recent years which is anticipated to boost demand for mydriatic eyedrops during the forecast period.

Regional Analysis:

North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. Increasing prevalence of eye diseases, growing geriatric population, and high adoption of modern healthcare facilities are some major factors contributing to the growth of this regional market. In addition, presence of key players such as Bausch & Lomb and Allergan plc., with extensive distribution networks is also supporting the growth in North America eyedrops market.

Growth Factors:

  • Increasing prevalence of eye disorders: The increasing prevalence of various eye disorders is one of the key growth drivers for the mydriatic eyedrops market. According to a study by The National Eye Institute, around 2 million people in the U.S are affected by glaucoma and this number is expected to increase to 3 million by 2020. This will create a high demand for mydriatic eyedrops in order to treat these conditions.
  • Rising awareness about eye care: There has been a rising awareness about the importance of eye care in recent years, which is driving people towards using mydriatic eyedrops for better vision and prevention of various eye diseases. This is also contributing significantly towards the growth of this market.
  • Technological advancements: The advent of new technologies has led to significant improvements in the design and performance of mydriatic eyedrops, making them more effective and safe than ever before. This is resulting in an increased adoption rate among consumers, thereby propelling market growth further..

Scope Of The Report

Report Attributes

Report Details

Report Title

Mydriatic Eyedrops Market Research Report

By Type

Atropine, Homatropine, Dolly, Others

By Application

Adult, Children

By Companies

Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon, Viva Opti-Free, Bausch & Lomb, Systane, Rite Aid, Walgreens, Staples, Clear eyes

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Mydriatic Eyedrops Market Report Segments:

The global Mydriatic Eyedrops market is segmented on the basis of:


Atropine, Homatropine, Dolly, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Adult, Children

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Novartis AG
  2. Allergan, Inc.
  3. Meda Pharmaceuticals Inc
  4. Bausch & Lomb Inc
  5. Cigna
  6. Similasan Corporation
  7. Visine
  8. Alcon
  9. Viva Opti-Free
  10. Bausch & Lomb
  11. Systane
  12. Rite Aid
  13. Walgreens
  14. Staples
  15. Clear eyes

Global Mydriatic Eyedrops Market Overview

Highlights of The Mydriatic Eyedrops Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Atropine
    2. Homatropine
    3. Dolly
    4. Others
  1. By Application:

    1. Adult
    2. Children
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Mydriatic Eyedrops Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Mydriatic Eyedrops Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Mydriatic eyedrops are a type of medication that dilate the pupil (the black part of the eye) in order to make it easier to see in low light or during night time. Mydriatics are used to treat conditions such as glaucoma, myopia (nearsightedness), and cataracts.

Some of the major companies in the mydriatic eyedrops market are Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon, Viva Opti-Free, Bausch & Lomb, Systane, Rite Aid, Walgreens, Staples, Clear eyes.

The mydriatic eyedrops market is expected to grow at a compound annual growth rate of 5.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Mydriatic Eyedrops Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Mydriatic Eyedrops Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Mydriatic Eyedrops Market - Supply Chain
   4.5. Global Mydriatic Eyedrops Market Forecast
      4.5.1. Mydriatic Eyedrops Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Mydriatic Eyedrops Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Mydriatic Eyedrops Market Absolute $ Opportunity

5. Global Mydriatic Eyedrops Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Mydriatic Eyedrops Market Size and Volume Forecast by Type
      5.3.1. Atropine
      5.3.2. Homatropine
      5.3.3. Dolly
      5.3.4. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Mydriatic Eyedrops Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Mydriatic Eyedrops Market Size and Volume Forecast by Application
      6.3.1. Adult
      6.3.2. Children
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Mydriatic Eyedrops Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Mydriatic Eyedrops Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Mydriatic Eyedrops Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Mydriatic Eyedrops Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Mydriatic Eyedrops Demand Share Forecast, 2019-2029

9. North America Mydriatic Eyedrops Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Mydriatic Eyedrops Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Mydriatic Eyedrops Market Size and Volume Forecast by Application
      9.4.1. Adult
      9.4.2. Children
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Mydriatic Eyedrops Market Size and Volume Forecast by Type
      9.7.1. Atropine
      9.7.2. Homatropine
      9.7.3. Dolly
      9.7.4. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Mydriatic Eyedrops Demand Share Forecast, 2019-2029

10. Latin America Mydriatic Eyedrops Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Mydriatic Eyedrops Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Mydriatic Eyedrops Market Size and Volume Forecast by Application
      10.4.1. Adult
      10.4.2. Children
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Mydriatic Eyedrops Market Size and Volume Forecast by Type
      10.7.1. Atropine
      10.7.2. Homatropine
      10.7.3. Dolly
      10.7.4. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Mydriatic Eyedrops Demand Share Forecast, 2019-2029

11. Europe Mydriatic Eyedrops Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Mydriatic Eyedrops Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Mydriatic Eyedrops Market Size and Volume Forecast by Application
      11.4.1. Adult
      11.4.2. Children
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Mydriatic Eyedrops Market Size and Volume Forecast by Type
      11.7.1. Atropine
      11.7.2. Homatropine
      11.7.3. Dolly
      11.7.4. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Gowth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Mydriatic Eyedrops Demand Share, 2019-2029

12. Asia Pacific Mydriatic Eyedrops Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Mydriatic Eyedrops Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Mydriatic Eyedrops Market Size and Volume Forecast by Application
      12.4.1. Adult
      12.4.2. Children
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Mydriatic Eyedrops Market Size and Volume Forecast by Type
      12.7.1. Atropine
      12.7.2. Homatropine
      12.7.3. Dolly
      12.7.4. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Mydriatic Eyedrops Demand Share, 2019-2029

13. Middle East & Africa Mydriatic Eyedrops Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Mydriatic Eyedrops Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Mydriatic Eyedrops Market Size and Volume Forecast by Application
      13.4.1. Adult
      13.4.2. Children
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Mydriatic Eyedrops Market Size and Volume Forecast by Type
      13.7.1. Atropine
      13.7.2. Homatropine
      13.7.3. Dolly
      13.7.4. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Mydriatic Eyedrops Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Mydriatic Eyedrops Market: Market Share Analysis
   14.2. Mydriatic Eyedrops Distributors and Customers
   14.3. Mydriatic Eyedrops Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Novartis AG Overview Financials Developments Strategic Outlook
      14.4.2. Allergan, Inc. Overview Financials Developments Strategic Outlook
      14.4.3. Meda Pharmaceuticals Inc Overview Financials Developments Strategic Outlook
      14.4.4. Bausch & Lomb Inc Overview Financials Developments Strategic Outlook
      14.4.5. Cigna Overview Financials Developments Strategic Outlook
      14.4.6. Similasan Corporation Overview Financials Developments Strategic Outlook
      14.4.7. Visine Overview Financials Developments Strategic Outlook
      14.4.8. Alcon Overview Financials Developments Strategic Outlook
      14.4.9. Viva Opti-Free Overview Financials Developments Strategic Outlook
      14.4.10. Bausch & Lomb Overview Financials Developments Strategic Outlook
      14.4.11. Systane Overview Financials Developments Strategic Outlook
      14.4.12. Rite Aid Overview Financials Developments Strategic Outlook
      14.4.13. Walgreens Overview Financials Developments Strategic Outlook
      14.4.14. Staples Overview Financials Developments Strategic Outlook
      14.4.15. Clear eyes Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us